Biotech firm Deepull raises €50 million in round led by Columbus Venture partners

by Columbus Venture Partners

The round was co-led by prominent investors Columbus Venture Partners, Panakès Partners, and Mérieux Equity Partners. The financing round also had strong participation from existing investors Asabys...

Read more

La SICC Innvierte del CDTI Innovación invierte, junto con cuatro coinversores, en deepull para acelerar el diagnóstico de la sepsis

by CDTI Innovación

La sepsis causa o contribuye directamente a 1 de cada 3 muertes hospitalarias en EE. UU., y el shock séptico tiene una tasa de mortalidad del 30-40% a nivel mundial. La dificultad para identificar in...

Read more

Cuatrecasas advises Deepull on a €50 million Series C funding round

by Cuatrecasas

The funding from this new round is a crucial milestone for Deepull as it moves towards completing the clinical studies of its diagnostic system. The aim is to offer a transformative diagnostic solutio...

Read more

COFIDES supports the consolidation in Mexico of the biotech company Green Universe

by COFIDES

Through a co-investment loan of €200k, COFIDES will finance the consolidation of the aforementioned company's subsidiary in Mexico, operating since 2014 and focused on commercial activities and on c...

Read more

BioSintNA, en Food4Future: 'Las empresas navarras deben estar preparadas para el crecimiento exponencial de la biología sintética'

by SODENA

Las empresas navarras deben estar preparadas para el crecimiento exponencial del mercado de la biología sintética, capitalizar su potencial, identificando y evaluando el mercado y su atractivo y des...

Read more

ReproNovo raises $65 million Series A financing to advance phase 2 clinical trials of novel therapies in reproductive medicine and women’s health

by Ysios Capital

ReproNovo, a company dedicated to developing innovative treatments for reproductive medicine and women’s health, today announced the successful closing of a $65 million Series A financing round. The...

Read more

aptaTargets, from Inveready and CDTI portfolio, transfers ApTOLL to Merck

by Inveready Asset Management

Under the terms of the agreement, Merck assumes responsibility for the global development and commercialization of ApTOLL, with aptaTargets providing ongoing transitional support. The transaction incl...

Read more

España irrumpe en el 'top 5' de Europa en sanidad pública y se convierte en un imán para el capital privado

by EY - Ernst & Young

España se sitúa como el cuarto país en inversión total en sanidad pública en Europa, con 134 mil millones de euros, superada solo por Alemania (489 mil millones), Francia (313 mil millones) e Ita...

Read more

GoHub Ventures participates in Aeon's €8.2m seed round to scale its AI-based preventative health platform

by GoHub Ventures

The round was led by London-based VC Concentric, with participation from Calm/Storm Ventures, GoHub Ventures, Kadmos Capital, EWOR, and Swiss super angel investor Daniel Gutenberg, known for backing 1...

Read more

SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines

by Asabys Partners

The Series B financing was co-led by new investors EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Fund, as well as all existing investors: New Enterprise Associates, UCB ...

Read more

Aortyx raises €13.8 million in a Series A led by Ship2B Ventures and Clave Capital to bring its vascular patch to patient

by Ship2B Ventures

The round was led by Ship2B Ventures through its BSocial Impact Fund and Clave Capital, via its Clave Innohealth vehicle (supported by CDTI-Innvierte). Additional participants included Nara Capital, t...

Read more

Cuatrecasas advises Sanofi Ventures and EQT Life Sciences on the largest investment round in a healthtech company in Spain, aimed at boosting gene therapies

by Cuatrecasas

The round, which also included participation from Roche Venture Fund and returning investors such as New Enterprise Associates, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis Venture Fund, an...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Alantra Private Equity strengthens AIVOR...

by Alantra

AIVORIQ has grown significantly since Alantra PE launched the project....

Photos Stream